EXICURE, INC. Accounts Payable and Accrued Liabilities, Current
EXICURE, INC. (XCUR) had Accounts Payable and Accrued Liabilities, Current of $3.10 thousand as of 2017-08-31, per its 10-Q filed 2017-09-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2017-09-12
- 2017-08-31: Accounts Payable and Accrued Liabilities, Current $3.10K.
- 2017-05-31: Accounts Payable and Accrued Liabilities, Current $2.73K.
- 2017-02-28: Accounts Payable and Accrued Liabilities, Current $10.00.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2017-08-31 | $3.10K 10-Q · filed 2017-09-12 |
| 2017-05-31 | $2.73K 10-Q · filed 2017-07-11 |
| 2017-02-28 | $10.00 10-Q · filed 2017-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |